The only other treatment approved in the proposed high-risk bladder cancer indication is not in treatment guidelines due to lack of efficacy. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
